Oct 10, 2022 02:31 PM (GMT+8) · EqualOcean
Hua Medicine (Chinese:华领医药) announced that its New Drug Application, HuaTangNing (Chinese:华堂宁®), has been approved by NMPA (National Medical Products Administration). Founded in 2011, Hua Medicine is an innovative drug development company in China focused on developing novel therapies for patients with unmet medical needs. HuaTangNing, the company's core product, is the first approved glucokinase activator (GKA) worldwide and the first novel drug for type 2 diabetes mellitus (T2DM) in China.

Source: